Search Results 61-70 of 20338 for Ulcerative%2Bcolitis

  1. Doctors and departments - Mayo Clinic

    Ulcerative colitis. Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in ...

  2. Tofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis - Mayo Clinic

    So this will be a welcome addition to our armamentarium of treatments for ulcerative colitis. It's also the first IBD drug approved with this mechanism of ...

  3. Mesalamine dose may lower marker of bowel inflammation Videos - Mayo Clinic

    A lower level of calprotectin is associated with a lower risk of having an ulcerative colitis flare. In inflammatory bowel disease (IBD), there can be a ...

  4. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  5. Mayo Clinic Radio: IBD / food allergies / Convergence Science Program

    There are two common types: ulcerative colitis, which causes ulcers, or sores, in the lining of the large intestine and rectum, and Crohn's disease, which ...

  6. Mayo Clinic Q and A: What is inflammatory bowel disease?

    Ulcerative colitis involves inflammation along the superficial lining of the large intestine (colon) and rectum while Crohn's disease involves inflammation and ...

  7. Pseudomembranous colitis - Symptoms & causes - Mayo Clinic

    Colitis is inflammation of the colon. Inflammation is the immune system reaction to disease or injury. An inflammatory reaction increases blood flow, releases ...

  8. Doctors and departments - Mayo Clinic

    Ulcerative colitis. Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in ...

  9. Long-Term Study Of CP-690,550 in Subjects with Ulcerative Colitis - Mayo Clinic

    This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP- ...

  10. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    About this study ... Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon ...